
|
|
09/01/2020 12:00 AM EDT

|
|
Manage your Subscriptions | Department of Justice Privacy Policy | GovDelivery Privacy Policy
Genentech had no approved medicine when investors rushed through the door. Today’s AI leaders are taking a very different path. ...
No comments:
Post a Comment